VistaGen Therapeutics Inc. (VTGN) NASDAQ
$4.80 0.05 (1.05%)
Market Cap: $128.37M
As of 04/29/24 02:29 PM EDT. Market open.
VistaGen Therapeutics Inc. (VTGN)
NASDAQ
$4.80
0.05 (1.05%)
Market Cap: $128.37M
As of 04/29/24 02:29 PM EDT. Market open.
Add to Portfolio
we have developed a versatile stem cell technology platform based on the controlled differentiation of human pluripotent stem cells into mature, non-transformed, human cells which can be used to create novel bioassay systems for predictive toxicology, drug metabolism screening, drug discovery, drug rescue and cell therapy. we believe our stem cell technology platform, human clinical trials in a ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
33
URL
Address
.
PRICE CHART FOR VISTAGEN THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$4.92
Previous Close
$4.75
Days Range
$4.67 - $4.84
52 week range
$1.62 - $24.71
Volume
138,753
Avg. Volume (30 days)
246,779
Market Cap
$128.37M
Dividend Yield
-
P/E
-
Shares Outstanding
27,025,209
Open
$4.92
Previous Close
$4.75
Days Range
$4.67 - $4.84
52 week range
$1.62 - $24.71
Volume
138,753
Avg. Volume (30 days)
246,779
Market Cap
$128.37M
Dividend Yield
-
P/E
-
Shares Outstanding
27,025,209
FINANCIAL STATEMENTS FOR VISTAGEN THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR VISTAGEN THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| COMMODORE CAPITAL LP | 10% Owner | Aug 07, 2023 | Buy | $23.15 | 775,756 | 17,961,079 | 1,575,000 | Aug 09, 2023, 04:10 PM |
| DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | Dec 30, 2022 | Option Exercise | $0.09 | 5,000 | 438 | 105,111 | Jan 03, 2023, 04:11 PM |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | Dec 30, 2022 | Option Exercise | $0.09 | 5,000 | 438 | 158,998 | Jan 03, 2023, 04:10 PM |
| GIN JERRY B | Director | Aug 18, 2022 | Buy | $0.18 | 100,000 | 17,870 | 100,000 | Aug 22, 2022, 05:12 PM |
| GIN JERRY B | Director | Aug 18, 2022 | Buy | $0.18 | 100,000 | 17,870 | 100,000 | Aug 22, 2022, 05:12 PM |
| Adler Reid G. | CHIEF LEGAL OFFICER | Aug 17, 2022 | Buy | $0.17 | 300,000 | 50,910 | 334,629 | Aug 19, 2022, 03:45 PM |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | Aug 17, 2022 | Buy | $0.17 | 600,000 | 103,200 | 626,234 | Aug 18, 2022, 03:56 PM |
| DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | Jul 30, 2022 | Option Exercise | $0.75 | 5,000 | 3,740 | 100,111 | Jul 15, 2022, 04:30 PM |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | Jun 30, 2022 | Option Exercise | $0.75 | 5,000 | 3,740 | 153,998 | Jul 15, 2022, 04:30 PM |
| Smith Mark Alan | CHIEF MEDICAL OFFICER | Jun 30, 2022 | Option Exercise | $0.75 | 5,000 | 3,740 | 19,915 | Jul 15, 2022, 04:30 PM |
| Venrock Healthcare Capital Partners II, L.P. | 10% Owner | Jul 12, 2022 | Sale | $0.89 | 60,000 | 53,400 | 20,637,286 | Jul 14, 2022, 05:33 PM |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | May 12, 2022 | Option Exercise | $1.00 | 100,000 | 100,000 | 148,998 | May 16, 2022, 01:39 PM |
| DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | Jan 11, 2022 | Option Exercise | $1.00 | 18,750 | 18,750 | 94,571 | Jan 12, 2022, 05:21 PM |
| Smith Mark Alan | CHIEF MEDICAL OFFICER | Dec 31, 2021 | Option Exercise | $1.66 | 2,655 | 4,401 | 14,915 | Jan 03, 2022, 04:25 PM |
| DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | Dec 31, 2021 | Option Exercise | $1.66 | 3,575 | 5,926 | 75,821 | Jan 03, 2022, 04:20 PM |
| SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | Dec 31, 2021 | Option Exercise | $1.66 | 3,623 | 6,005 | 64,958 | Jan 03, 2022, 04:19 PM |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | Dec 31, 2021 | Option Exercise | $1.66 | 3,623 | 6,005 | 48,998 | Jan 03, 2022, 04:17 PM |
| DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | Sep 07, 2021 | Sale | $3.13 | 30,000 | 93,750 | 72,786 | Sep 08, 2021, 06:58 PM |
| SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | Aug 17, 2021 | Buy | $2.73 | 3,750 | 10,238 | 34,641 | Aug 18, 2021, 06:20 PM |
| Smith Mark Alan | CHIEF MEDICAL OFFICER | Jun 30, 2021 | Option Exercise | $1.95 | 2,260 | 4,399 | 12,260 | Jul 02, 2021, 04:11 PM |
| DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | Jun 30, 2021 | Option Exercise | $1.95 | 3,044 | 5,925 | 13,044 | Jul 02, 2021, 04:10 PM |
| DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | Jun 30, 2021 | Option Exercise | $0.94 | 89,742 | 84,328 | 102,786 | Jul 02, 2021, 04:10 PM |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | Jun 30, 2021 | Option Exercise | $1.95 | 5,000 | 9,732 | 45,375 | Jul 02, 2021, 04:10 PM |
| SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | Jun 30, 2021 | Option Exercise | $1.95 | 3,391 | 6,601 | 91,115 | Jul 02, 2021, 04:10 PM |
| Underdown Brian J. | Director | Mar 19, 2021 | Option Exercise | $1.50 | 2,500 | 3,750 | 2,500 | Mar 22, 2021, 07:06 PM |
| SAXE JON S | Director | Mar 19, 2021 | Option Exercise | $1.50 | 2,500 | 3,750 | 5,751 | Mar 22, 2021, 07:03 PM |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | Dec 31, 2020 | Option Exercise | $0.45 | 5,000 | 2,261 | 35,375 | Jan 04, 2021, 04:58 PM |
| DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | Dec 31, 2020 | Option Exercise | $0.45 | 5,000 | 2,261 | 10,000 | Jan 04, 2021, 04:57 PM |
| Smith Mark Alan | CHIEF MEDICAL OFFICER | Dec 31, 2020 | Option Exercise | $0.45 | 5,000 | 2,261 | 10,000 | Jan 04, 2021, 04:55 PM |
| SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | Dec 31, 2020 | Option Exercise | $0.45 | 5,000 | 2,261 | 87,724 | Jan 04, 2021, 04:48 PM |
| SAXE JON S | Director | Aug 21, 2020 | Buy | $0.69 | 30,000 | 20,700 | 50,000 | Aug 24, 2020, 04:31 PM |
| SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | Jun 30, 2020 | Option Exercise | $0.45 | 5,000 | 2,240 | 67,724 | Jul 01, 2020, 05:35 PM |
| Smith Mark Alan | CHIEF MEDICAL OFFICER | Jun 30, 2020 | Option Exercise | $0.45 | 5,000 | 2,240 | 5,000 | Jul 01, 2020, 05:33 PM |
| DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | Jun 30, 2020 | Option Exercise | $0.45 | 5,000 | 2,240 | 5,000 | Jul 01, 2020, 05:28 PM |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | Jun 30, 2020 | Option Exercise | $0.45 | 5,000 | 2,240 | 30,375 | Jul 01, 2020, 05:20 PM |
| SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | Nov 20, 2019 | Buy | $0.34 | 15,000 | 5,100 | 15,000 | Nov 21, 2019, 07:52 PM |
| SAXE JON S | Director | Mar 14, 2019 | Buy | $1.27 | 7,920 | 10,086 | 20,000 | Mar 14, 2019, 05:22 PM |
| SAXE JON S | Director | Mar 13, 2019 | Buy | $1.26 | 12,080 | 15,201 | 12,080 | Mar 14, 2019, 05:22 PM |
| SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | Mar 13, 2019 | Option Exercise | $1.50 | 2,500 | 3,750 | 62,724 | Mar 14, 2019, 05:12 PM |
| SAXE JON S | Director | Jan 29, 2019 | Option Exercise | $1.50 | 1,375 | 2,063 | 3,251 | Jan 30, 2019, 04:05 PM |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | Jan 14, 2019 | Option Exercise | $1.50 | 25,375 | 38,063 | 25,375 | Jan 15, 2019, 04:29 PM |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | Oct 15, 2013 | Option Exercise | $0.64 | 10,000 | 6,400 | 312,174 | Oct 15, 2013, 06:20 PM |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | Jun 27, 2013 | Option Exercise | $0.64 | 50,000 | 32,000 | 302,174 | Jun 27, 2013, 03:39 PM |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | Dec 06, 2012 | Option Exercise | $0.50 | 100,000 | 50,000 | 252,174 | Dec 06, 2012, 12:58 PM |
| Cato Allen Easley | 10% Owner | Dec 15, 2011 | Option Exercise | $9999.44 | 11,363 | 113,623,642 | 28,497 | Jan 09, 2012, 04:50 PM |
| CATO HOLDING CO | 10% Owner | Dec 15, 2011 | Option Exercise | $471727.00 | 424,124 | 200,070,742,148 | 3,310,836 | Jan 09, 2012, 01:01 PM |
| SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | Dec 20, 2011 | Option Exercise | $0.88 | 113,636 | 100,000 | 1,204,468 | Dec 22, 2011, 11:16 AM |
| SAXE JON S | Director | Dec 14, 2011 | Option Exercise | $1.25 | 2,784 | 3,480 | 20,138 | Dec 16, 2011, 08:23 PM |
| SAXE JON S | Director | May 11, 2011 | Option Exercise | $3.50 | 17,354 | 60,739 | 17,354 | May 25, 2011, 06:57 PM |
| RICE A. FRANKLIN | CHIEF FINANCIAL OFFICER | May 11, 2011 | Option Exercise | $3.50 | 229,521 | 803,324 | 229,521 | May 25, 2011, 06:55 PM |
| SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | May 11, 2011 | Option Exercise | $3.50 | 545,416 | 1,908,956 | 545,416 | May 25, 2011, 06:53 PM |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | May 11, 2011 | Option Exercise | $3.50 | 76,087 | 266,305 | 76,087 | May 25, 2011, 06:52 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| COMMODORE CAPITAL LP | 10% Owner | 08/07/2023 | 17,961,079 |
| DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | 12/30/2022 | 438 |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | 12/30/2022 | 438 |
| GIN JERRY B | Director | 08/18/2022 | 17,870 |
| GIN JERRY B | Director | 08/18/2022 | 17,870 |
| Adler Reid G. | CHIEF LEGAL OFFICER | 08/17/2022 | 50,910 |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | 08/17/2022 | 103,200 |
| DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | 07/30/2022 | 3,740 |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | 06/30/2022 | 3,740 |
| Smith Mark Alan | CHIEF MEDICAL OFFICER | 06/30/2022 | 3,740 |
| Venrock Healthcare Capital Partners II, L.P. | 10% Owner | 07/12/2022 | 53,400 |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | 05/12/2022 | 100,000 |
| DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | 01/11/2022 | 18,750 |
| Smith Mark Alan | CHIEF MEDICAL OFFICER | 12/31/2021 | 4,401 |
| DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | 12/31/2021 | 5,926 |
| SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | 12/31/2021 | 6,005 |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | 12/31/2021 | 6,005 |
| DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | 09/07/2021 | 93,750 |
| SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | 08/17/2021 | 10,238 |
| Smith Mark Alan | CHIEF MEDICAL OFFICER | 06/30/2021 | 4,399 |
| DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | 06/30/2021 | 5,925 |
| DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | 06/30/2021 | 84,328 |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | 06/30/2021 | 9,732 |
| SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | 06/30/2021 | 6,601 |
| Underdown Brian J. | Director | 03/19/2021 | 3,750 |
| SAXE JON S | Director | 03/19/2021 | 3,750 |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | 12/31/2020 | 2,261 |
| DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | 12/31/2020 | 2,261 |
| Smith Mark Alan | CHIEF MEDICAL OFFICER | 12/31/2020 | 2,261 |
| SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | 12/31/2020 | 2,261 |
| SAXE JON S | Director | 08/21/2020 | 20,700 |
| SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | 06/30/2020 | 2,240 |
| Smith Mark Alan | CHIEF MEDICAL OFFICER | 06/30/2020 | 2,240 |
| DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | 06/30/2020 | 2,240 |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | 06/30/2020 | 2,240 |
| SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | 11/20/2019 | 5,100 |
| SAXE JON S | Director | 03/14/2019 | 10,086 |
| SAXE JON S | Director | 03/13/2019 | 15,201 |
| SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | 03/13/2019 | 3,750 |
| SAXE JON S | Director | 01/29/2019 | 2,063 |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | 01/14/2019 | 38,063 |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | 10/15/2013 | 6,400 |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | 06/27/2013 | 32,000 |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | 12/06/2012 | 50,000 |
| Cato Allen Easley | 10% Owner | 12/15/2011 | 113,623,642 |
| CATO HOLDING CO | 10% Owner | 12/15/2011 | 200,070,742,148 |
| SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | 12/20/2011 | 100,000 |
| SAXE JON S | Director | 12/14/2011 | 3,480 |
| SAXE JON S | Director | 05/11/2011 | 60,739 |
| RICE A. FRANKLIN | CHIEF FINANCIAL OFFICER | 05/11/2011 | 803,324 |
| SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | 05/11/2011 | 1,908,956 |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | 05/11/2011 | 266,305 |
Load More Insider Transactions
FUNDS WITH A POSITION IN VISTAGEN THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 346,683 | 0.00005% | 293.75% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 274,472 | 0.00015% | 275.15% | Other |
BUYBACK ANNOUNCEMENT(S) FOR VISTAGEN THERAPEUTICS INC
LOADING...